中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
合肥物质科学研究院 [4]
上海药物研究所 [2]
采集方式
OAI收割 [6]
内容类型
期刊论文 [6]
发表日期
2022 [1]
2021 [1]
2018 [1]
2014 [1]
2013 [1]
2008 [1]
更多
学科主题
Oncology [1]
筛选
浏览/检索结果:
共6条,第1-6条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
作者升序
作者降序
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
期刊论文
OAI收割
TRANSLATIONAL CANCER RESEARCH, 2022
作者:
He, Libin
;
Shen, Xiabo
;
Liu, Yiyuan
;
Gao, Lu
;
Wu, Jiayi
  |  
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)
apatinib
case report
Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study
期刊论文
OAI收割
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Shen, Xia-Bo
;
Li, Guang-Liang
;
Zheng, Ya-Bing
;
Chen, Zhan-Hong
;
Cao, Wen-Ming
  |  
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2021/11/01
Advanced breast cancer (ABC)
aromatase inhibitors (AIs)
everolimus (EVE)
fulvestrant (FUL)
retrospective study
Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer
期刊论文
OAI收割
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30
-
  |  
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2020/10/26
PHASE-I
POSTMENOPAUSAL WOMEN
HDAC INHIBITOR
MULTICENTER
ENTINOSTAT
TAMOXIFEN
CS055/HBI-8000
RESISTANCE
LETROZOLE
TRIAL
Advanced breast cancer
hormone receptor-positive
chidamide
exemestane
Everolimus and zoledronic acid-a potential synergistic treatment for lung adenocarcinoma bone metastasis
期刊论文
OAI收割
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2014, 卷号: 46
-
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2020/10/26
HORMONE-RELATED PROTEIN
MULTIPLE-MYELOMA CELLS
BREAST-CANCER
PHASE-II
PROSTATE-CANCER
MAMMALIAN TARGET
ADVANCED NSCLC
SCID MICE
IN-VITRO
BISPHOSPHONATES
zoledronic acid
everolimus
lung adenocarcinoma
bone metastasis
Grb14 as an Independent Good Prognosis Factor for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
期刊论文
OAI收割
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 卷号: 43, 期号: 11, 页码: 1064-1072
作者:
Huang, Ou
;
Jiang, Min
;
Zhang, Xi
;
Xie, Zuoquan
;
Chen, Xiaosong
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2019/01/08
grb14
breast cancer
locally advanced
neoadjuvant chemotherapy
prognosis